Guided by the mission of “making life better through nuclear technology,” CGN focuses on the nuclear technology application industry, advancing along the “A+” strategy towards the three goals of “more beautiful, safer, and healthier.” In the field of accelerators and irradiation business, CGN takes up a large market share in the domestic manufacturing of industrial electron accelerators, covering high-, medium-, and low-energy accelerators, securing a first-tier position in China’s nuclear technology application sector. In new materials business, CGN is a leading manufacturer of polymer composite materials in China and one of the main producers of specialty cable compounds. In measurement and control equipment business under entrusted management, CGN’s primary markets include customs, border inspection, and nuclear power, with business scale ranking among the top nationwide. In healthcare, CGN has introduced internationally-advanced proton therapy technology for cancer treatmen,, established a proton equipment manufacturing base, and is committed to achieving self-reliance and control over high-end proton therapy equipment technology and products. In addition, it produces medical radioisotopes such as Germanium-68 [68Ge] and Iodine-123 [123I] using medium-energy proton cyclotrons and develops medical generators based on Germanium-68 [68Ge], steadily building a complete nuclear medicine industry chain.